We are live on
!
Find out more
RGC
Roberts, Glore & Co Portfolio holdings
AUM
$364M
1-Year Est. Return
19.54%
This Fund
S&P 500
This Quarter
Est. Return
+1.61%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$328M
AUM Growth
-$9.02M
(-2.7%)
Cap. Flow
-$9.59M
Cap. Flow
% of AUM
-2.92%
Top 10 Holdings %
Top 10 Hldgs %
36.34%
Holding
213
New
5
Increased
48
Reduced
109
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$968K |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$747K |
| 3 |
NVO
Novo Nordisk
NVO
|
+$656K |
| 4 |
ASML
ASML
|
+$540K |
| 5 |
Applied Materials
AMAT
|
+$401K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$1.56M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24M |
| 3 |
Charles River Laboratories
CRL
|
+$964K |
| 4 |
Apple
AAPL
|
+$951K |
| 5 |
CVS Health
CVS
|
+$647K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Healthcare | 16.12% |
| 3 | Financials | 14.31% |
| 4 | Industrials | 8.77% |
| 5 | Communication Services | 6.31% |
Similar funds
VBFP
EW
RBFC
ACM
DCP
MA
SWA
OAJ
Roberts, Glore & Co's Q1 2025 Portfolio in Review
As of Q1 2025, Roberts, Glore & Co held 213 positions worth $328M, down 2.7% from $337M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Roberts, Glore & Co's Q1 2025 filing shows 5 new, 48 increased, 109 reduced and 12 closed positions. Its largest new stake was iShares MSCI EAFE ETF: 12,006 shares worth $981K. The largest sale was Berkshire Hathaway Class B, an estimated $1.56M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- Roberts, Glore & Co's largest Q1 2025 buy was iShares MSCI EAFE ETF: 12,006 shares worth $981K.
- Roberts, Glore & Co added most to Vanguard S&P 500 ETF in Q1 2025, an estimated $747K increase.
- Roberts, Glore & Co's biggest Q1 2025 reduction was Berkshire Hathaway Class B, cutting an estimated $1.56M.
- Roberts, Glore & Co fully exited Charles River Laboratories in Q1 2025, selling an estimated $964K.
- Roberts, Glore & Co's ten largest holdings make up 36% of its $328M portfolio in Q1 2025.
- Roberts, Glore & Co opened 5 new positions and closed 12 in Q1 2025.
- Roberts, Glore & Co's portfolio value fell 2.7% quarter-over-quarter to $328M.
Based on Roberts, Glore & Co's 13F filing for Q1 2025, filed 9 May 2025.